Using a multivariate model to assess the interactive effects of demographics and lifestyle on the hematological profile

Estimation of Heart Rate Using Regression Models and Artificial Neural Network in Middle-Aged Adults

Purpose: Heart rate is the most commonly used indicator in clinical medicine to assess the functionality of the cardiovascular system. Most studies have focused on age-based equations to estimate the maximal heart rate, neglecting multiple factors that affect the accuracy of the prediction. Methods: We studied 121 middle-aged adults at an average age of 57.2years with an average body mass index (BMI) of 25.9. The participants performed on a power bike with a starting wattage of 0W that was increased by 25W every 3min until the experiment terminated. Ambulatory blood pressure and electrocardiography were monitored through gas metabolic analyzers for safety concerns. Six descriptive characteristics of participants were observed, which were further analyzed using a multivariate regression model and an artificial neural network (ANN). Results: The input variables for the multivariate regression model and ANN were selected by correlation for the reduction of dimension. The accuracy of estimation by multivariate regression model and ANN was 9.74 and 9.42%, respectively, which outperformed the traditional age-based model (with an accuracy of 10.31%). Conclusion: This study provides comprehensive approaches to estimate the maximal heart rate using multiple indicators, revealing that both the multivariate regression model and ANN incorporated with age, resting heart rate (RHR), and second-order heart rate (SOHR) are more accurate than univariate models.

Comparison of Diagnosis Accuracy between a Backpropagation Artificial Neural Network Model and Linear Regression in Digestive Disease Patients: an Empirical Research

Introduction

A Noninvasive diagnosis model for digestive diseases is the vital issue for the current clinical research. Our systematic review is aimed at demonstrating diagnosis accuracy between the BP-ANN algorithm and linear regression in digestive disease patients, including their activation function and data structure.

Methods

We reported the systematic review according to the PRISMA guidelines. We searched related articles from seven electronic scholarly databases for comparison of the diagnosis accuracy focusing on BP-ANN and linear regression. The characteristics, patient number, input/output marker, diagnosis accuracy, and results/conclusions related to comparison were extracted independently based on inclusion criteria.

Results

Nine articles met all the criteria and were enrolled in our review. Of those enrolled articles, the publishing year ranged from 1991 to 2017. The sample size ranged from 42 to 3222 digestive disease patients, and all of the patients showed comparable biomarkers between the BP-ANN algorithm and linear regression. According to our study, 8 literature demonstrated that the BP-ANN model is superior to linear regression in predicting the disease outcome based on AUROC results. One literature reported linear regression to be superior to BP-ANN for the early diagnosis of colorectal cancer.

Conclusion

The BP-ANN algorithm and linear regression both had high capacity in fitting the diagnostic model and BP-ANN displayed more prediction accuracy for the noninvasive diagnosis model of digestive diseases. We compared the activation functions and data structure between BP-ANN and linear regression for fitting the diagnosis model, and the data suggested that BP-ANN was a comprehensive recommendation algorithm.

Epigenome-wide association studies for systemic autoimmune diseases: The road behind and the road ahead

Epigenetics is known to be an important mechanism in the pathogenesis of autoimmune diseases. Epigenetic variations can act as integrators of environmental and genetic exposures and propagate activated states in immune cells. Studying epigenetic alterations by means of genome-wide approaches promises to unravel novel molecular mechanisms related to disease etiology, disease progression, clinical manifestations and treatment responses. This paper reviews what we have learned in the last five years from epigenome-wide studies for three systemic autoimmune diseases, namely systemic lupus erythematosus, primary Sjögren's syndrome, and rheumatoid arthritis. We examine the degree of epigenetic sharing between different diseases and the possible mediating role of epigenetic associations in genetic and environmental risks. Finally, we also shed light into the use of epigenetic markers towards a better precision medicine regarding disease prediction, prevention and personalized treatment in systemic autoimmunity.